5,6,7-Trinor-4,8-inter-m-phenylene PGI2 derivatives and pharmaceutical compositions containing them
申请人:TORAY INDUSTRIES, INC.
公开号:EP0024943A1
公开(公告)日:1981-03-11
Pharmaceutically useful compounds possessing platelet aggregation-inhibiting and hypotensive anti-ulcer activity and having improved stability as compared with Prostaglandin I2 (PGI2) are provided by 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives such as 5,6,7-trinor-4, 8-inter-m-phenylene- 16,17,18,19,20- pentanor-15-phenyl PGI2. Also, pharmaceutical compositions containing them.
与前列腺素 I2 (PGI2)相比,5,6,7-三去甲-4,8-间亚苯基 PGI2 衍生物具有抑制血小板聚集和降压抗溃疡活性,并具有更好的稳定性,例如 5,6,7-三去甲-4,8-间亚苯基-16,17,18,19,20-戊-15-苯基 PGI2。 此外,还提供了含有这些化合物的药物组合物。